Literature DB >> 6570084

Responses of tolerant and nontolerant Staphylococcus aureus strains to methicillin treatment in an experimental infection in mice.

W H Goessens, P Fontijne, M F Michel.   

Abstract

Staphylococcus aureus strains can be divided into tolerant and nontolerant strains on the basis of their survival in vitro in the presence of high concentrations of methicillin (greater than or equal to 64 micrograms/ml). A strain is defined as tolerant if more than 2% of the inoculum survives under these conditions. The response of five susceptible and five tolerant S. aureus strains to treatment with methicillin was studied in an experimental thigh infection in mice. Animals were treated with one and two injections of methicillin (2.5 mg per mouse). At the end of treatment, the number of CFUs in the thigh muscles infected with the susceptible strains was found to be significantly lower than that in the thigh muscles infected with the tolerant

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6570084      PMCID: PMC180033          DOI: 10.1128/AAC.26.6.829

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  9 in total

1.  Virulence to mice of Staphylococcus pyogenes: its measurement and its relation to certain in vitro properties.

Authors:  F R SELBIE; R D SIMON
Journal:  Br J Exp Pathol       Date:  1952-08

2.  Simplified, accurate method for antibiotic assay of clinical specimens.

Authors:  J V Bennett; J L Brodie; E J Benner; W M Kirby
Journal:  Appl Microbiol       Date:  1966-03

3.  Oxacillin-tolerant staphylococcal bacteremia in children.

Authors:  M D Hilty; J S Venglarcik; G K Best
Journal:  J Pediatr       Date:  1980-06       Impact factor: 4.406

4.  Significance of methicillin tolerance in experimental staphylococcal endocarditis.

Authors:  P L Goldman; R G Petersdorf
Journal:  Antimicrob Agents Chemother       Date:  1979-06       Impact factor: 5.191

5.  Clinical significance of tolerant strains of Staphylococcus aureus in patients with endocarditis.

Authors:  K R Rajashekaraiah; T Rice; V S Rao; D Marsh; B Ramakrishna; C A Kallick
Journal:  Ann Intern Med       Date:  1980-12       Impact factor: 25.391

6.  The role of antibiotic tolerance in the response to treatment of pyelonephritis due to Staphylococcus aureus in rats.

Authors:  P A Guze; G M Kalmanson; L B Guze
Journal:  J Infect Dis       Date:  1982-02       Impact factor: 5.226

7.  Tolerance percentage as a criterion for the detection of tolerant Staphylococcus aureus strains.

Authors:  W H Goessens; P Fontijne; M van Raffe; M F Michel
Journal:  Antimicrob Agents Chemother       Date:  1984-05       Impact factor: 5.191

8.  Serious staphylococcal infections with strains tolerant to bactericidal antibiotics.

Authors:  A E Denny; L R Peterson; D N Gerding; W H Hall
Journal:  Arch Intern Med       Date:  1979-09

9.  A new type of penicillin resistance of Staphylococcus aureus.

Authors:  L D Sabath; N Wheeler; M Laverdiere; D Blazevic; B J Wilkinson
Journal:  Lancet       Date:  1977-02-26       Impact factor: 79.321

  9 in total
  8 in total

1.  Evaluation of oxacillin tolerance in Staphylococcus aureus by a novel method.

Authors:  B F Woolfrey; R T Lally; M N Ederer
Journal:  Antimicrob Agents Chemother       Date:  1985-09       Impact factor: 5.191

Review 2.  Problems in in vitro determination of antibiotic tolerance in clinical isolates.

Authors:  J C Sherris
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

3.  In vitro development and stability of tolerance to cloxacillin and vancomycin in Staphylococcus aureus.

Authors:  G P Voorn; J Thompson; W H Goessens; W C Schmal-Bauer; P H Broeders; M F Michel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-09       Impact factor: 3.267

Review 4.  Penicillin tolerance and treatment failure in group A streptococcal pharyngotonsillitis.

Authors:  G J van Asselt; R P Mouton; C P van Boven
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-02       Impact factor: 3.267

5.  Role of tolerance in treatment and prophylaxis of experimental Staphylococcus aureus endocarditis with vancomycin, teicoplanin, and daptomycin.

Authors:  G P Voorn; J Kuyvenhoven; W H Goessens; W C Schmal-Bauer; P H Broeders; J Thompson; M F Michel
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

6.  In vitro and in vivo evaluations of oxacillin efficiency against mecA-positive oxacillin-susceptible Staphylococcus aureus.

Authors:  Alexandros Ikonomidis; George Michail; Afroditi Vasdeki; Maria Labrou; Vasilis Karavasilis; Constantinos Stathopoulos; Antonios N Maniatis; Spyros Pournaras
Journal:  Antimicrob Agents Chemother       Date:  2008-08-11       Impact factor: 5.191

7.  Therapeutic effect of cefozopran (SCE-2787), a new parenteral cephalosporin, against experimental infections in mice.

Authors:  Y Iizawa; K Okonogi; R Hayashi; T Iwahi; T Yamazaki; A Imada
Journal:  Antimicrob Agents Chemother       Date:  1993-01       Impact factor: 5.191

8.  Efficacy of penicillin G, flucloxacillin, cefazolin, fusidic acid, vancomycin, rifampicin and fosfomycin in muscular infections in mice due to Staphylococcus aureus.

Authors:  R Haag
Journal:  Infection       Date:  1986 Jan-Feb       Impact factor: 3.553

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.